- Home
- SOHO vs CARM Comparison
SOHO vs CARM Comparison
Compare SOHO & CARM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SOHO
- CARM
- Stock Information
- Founded
- SOHO 2004
- CARM 2016
- Country
- SOHO United States
- CARM United States
- Employees
- SOHO N/A
- CARM N/A
- Industry
- SOHO Real Estate Investment Trusts
- CARM Biotechnology: Pharmaceutical Preparations
- Sector
- SOHO Real Estate
- CARM Health Care
- Exchange
- SOHO Nasdaq
- CARM Nasdaq
- Market Cap
- SOHO 18.0M
- CARM 16.4M
- IPO Year
- SOHO 2004
- CARM N/A
- Fundamental
- Price
- SOHO $0.89
- CARM $0.34
- Analyst Decision
- SOHO Hold
- CARM Hold
- Analyst Count
- SOHO 1
- CARM 5
- Target Price
- SOHO $1.50
- CARM $0.90
- AVG Volume (30 Days)
- SOHO 21.6K
- CARM 698.1K
- Earning Date
- SOHO 08-12-2025
- CARM 08-07-2025
- Dividend Yield
- SOHO N/A
- CARM N/A
- EPS Growth
- SOHO N/A
- CARM N/A
- EPS
- SOHO N/A
- CARM N/A
- Revenue
- SOHO $182,158,199.00
- CARM $19,964,000.00
- Revenue This Year
- SOHO $13.93
- CARM N/A
- Revenue Next Year
- SOHO N/A
- CARM N/A
- P/E Ratio
- SOHO N/A
- CARM N/A
- Revenue Growth
- SOHO 3.11
- CARM 32.45
- 52 Week Low
- SOHO $0.59
- CARM $0.14
- 52 Week High
- SOHO $1.54
- CARM $1.27
- Technical
- Relative Strength Index (RSI)
- SOHO 50.13
- CARM 41.94
- Support Level
- SOHO $0.84
- CARM $0.36
- Resistance Level
- SOHO $0.96
- CARM $0.41
- Average True Range (ATR)
- SOHO 0.05
- CARM 0.03
- MACD
- SOHO -0.00
- CARM -0.01
- Stochastic Oscillator
- SOHO 41.67
- CARM 13.26
About SOHO Sotherly Hotels Inc.
Sotherly Hotels Inc is engaged in Hotel operations. The company is a self-managed and self-administered lodging real estate investment trust that was formed to own, acquire, renovate, and reposition full-service, upscale, and upper-upscale hotel properties located in primary markets in the mid-Atlantic and southern United States. It generates revenue through the rooms, food, beverage, and other services. Geographically, the group has its presence in the regions of Florida, Georgia, Indiana, Maryland, North Carolina, Pennsylvania, Texas, and Virginia.
About CARM Carisma Therapeutics Inc.
CARISMA Therapeutics Inc is a clinical-stage cell therapy company focused on utilizing Carisma's proprietary chimeric antigen receptor macrophage and monocyte cell engineering platform to develop transformative immunotherapies to treat cancer and other serious diseases. The company has created a comprehensive cell therapy platform to enable the therapeutic use of engineered macrophages and monocytes, which belong to a subgroup of white blood cells called myeloid cells.